Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: A randomized, placebo-controlled trial-Reference-Cited by-同舟云学术

Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: A randomized, placebo-controlled trial

Published:2011-10 Issue:44 Volume:29 Page:7733-7739
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Treanor John J.,Sahly Hana El,King James,Graham Irene,Izikson Ruvim,Kohberger Robert,Patriarca Peter,Cox Manon

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference27 articles.

1. Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs;Katz;J Infect Dis,1989

2. Influenza A(H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule;Wood;Virology,1989

3. Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well-tolerated and induce protective immune responses in healthy adults;Powers;J Infect Dis,1995

4. Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults;Lakey;J Infect Dis,1996

5. Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults;Treanor;J Infect Dis,1996

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influenza B Virus Vaccine Innovation through Computational Design;Pathogens;2024-09-02

2. IDENTIFYING PLAUSIBLE RANGES FOR DIFFERENTIAL VACCINE EFFICACY ACROSS HIGH- AND LOW-INCOME SETTINGS: A SYSTEMATIC REVIEW, DESCRIPTIVE META-ANALYSIS, AND ILLUSTRATIVE EVIDENCE ANALYSIS;2024-08-01

3. Preliminary Findings From the Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE I) Study: A Randomized Controlled Trial;Clinical Infectious Diseases;2024-07-23

4. Preliminary findings from the Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE I) Study: a Randomized Controlled Trial;2024-05-17

5. An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza;npj Vaccines;2024-03-21